MiRNA Let-7a and Let-7d Are Induced by Globotriaosylceramide via NF-kB Activation in Fabry Disease
Nadine Maier(Medical University of Vienna), Philipp J. Hohensinner(Ludwig Boltzmann Institute for Age Research), Johann Wojta(Medical University of Vienna), Max Lenz(Ludwig Boltzmann Institute for Digital Health and Prevention), Gere Sunder–Plassmann(University of Vienna), Patrick Haider(Medical University of Vienna), Senta Graf(Medical University of Vienna), Bruno K. Podesser(Ludwig Boltzmann Institute for Cardiovascular Research), Constantin Gatterer(Medical University of Vienna), Manuel Salzmann(Medical University of Vienna), Christoph Kaun(University of Vienna), Walter S. Speidl(University of Applied Sciences St Pölten)
Cited by 9
Related Papers
Polar secretion of endothelin-1 by cultured endothelial cells.
|Journal of Biological Chemistry|1992|645
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
|The Lancet|2023|508
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
|Orphanet Journal of Rare Diseases|2015|345